Effect of Carmellose-based Artificial Tears on the Ocular Surface in Eyes After Laser in Situ Keratomileusis
Overview
Authors
Affiliations
Background: Strategies to minimize intraoperative ocular surface disturbance and accelerate postoperative ocular surface recovery are an important consideration to the surgeon.
Methods: Eighteen eyes of 10 patients were randomized to receive intraoperative and postoperative non-preserved balanced salt solution or non-preserved carboxymethylcellulose-based (carmellose) artificial tears. Presence and severity of McMonnies dry eye symptom survey score primary dry eye symptoms, fluorescein break-up time, and rose bengal staining were graded preoperatively and at 1 day, 1 week and 1 month postoperatively. Conjunctival impression cytology of the perilimbal conjunctiva was performed 1 month after surgery to determine goblet cell density.
Results: McMonnies dry eye symptoms were reported more frequently for the balanced salt solution group at 1 day, 1 week, and 1 month after surgery. Fluorescein break-up time was significantly greater in the carmellose-based group at 1 day (P < .01), 1 week (P = .04), and 1 month (P < .01) after surgery. The rose bengal staining score was significantly greater at 1 day (P < .01) and 1 week (P < .01) postoperatively for the balanced salt solution group. Mean goblet cell density for the carmellose-based group at 1 month postoperatively was significantly greater than that for the balanced salt solution group (P < .01).
Conclusions: Postoperative and intraoperative use of carmellose-based artificial tears resulted in significantly more rapid recovery of the ocular surface after LASIK when compared to balanced salt solution.
Canones-Zafra R, Abad J, Castellanos M, Muniz C, Sideroudi H, Teus M Ophthalmol Ther. 2023; 13(1):397-407.
PMID: 37996630 PMC: 10776532. DOI: 10.1007/s40123-023-00847-1.
Refractive surgery and dry eye - An update.
Nair S, Kaur M, Sharma N, Titiyal J Indian J Ophthalmol. 2023; 71(4):1105-1114.
PMID: 37026241 PMC: 10276666. DOI: 10.4103/IJO.IJO_3406_22.
Lv Y, Chu C, Liu K, Ru Y, Zhang Y, Lu X Sci Rep. 2021; 11(1):1184.
PMID: 33441928 PMC: 7807058. DOI: 10.1038/s41598-020-80849-2.
Wallerstein A, Jackson W, Chambers J, Moezzi A, Lin H, Simmons P Clin Ophthalmol. 2018; 12:839-848.
PMID: 29765198 PMC: 5944453. DOI: 10.2147/OPTH.S163744.
Hazarbassanov R, Queiroz-Hazarbassanov N, Barros J, Gomes J J Ophthalmol. 2018; 2018:4324590.
PMID: 29675272 PMC: 5838485. DOI: 10.1155/2018/4324590.